European Commission vs Big Pharma, or profit vs access?
Drug Discovery World
MARCH 29, 2023
For rare disease drugs, a variable RDP period of five, nine, or ten years, depending on the novelty of the drug. Moreover, an extra six months of RDP for drugs with full comparator clinical trials (rather than showing only that a drug is no worse than the standard of care).
Let's personalize your content